Designed for both Covered Entities and Manufacturers, attend this event to explore the latest developments in 340B with regards to transparency, HRSA 340B audits and other federal oversight activities.  Attendees examine the impact of recent policy changes, trends in pharmacy contracting and drug management practices, how to effectively leverage data analytics, and strategies to maintain compliance and ensure program integrity. This Summit includes tailored, closed-door sessions for Covered Entities and Manufacturers as well as shared content to maximize collaboration and knowledge -sharing.

Read on thinc360.com

The COVID-19 pandemic is shining a spotlight on the gaps in our inefficient fee-for-service system. Join this webinar to learn from industry partners and health care thought leaders as they discuss new strategies for succeeding in value-based care. Attendees will learn how a strong 340B and population health program can generate sustainable revenue streams, even during emergencies and times of uncertainty. Most Covered Entities are missing the majority of 340B referral claims, and more than 80% of these drug discounts go unclaimed. Using ACO data and new workflows, safety-net providers can more than double their 340B revenue.

For rural providers, there is a new risk-free ACO opportunity that can help transform primary care delivery and improve patient outcomes. Presenters will also discuss the fundamental pillars to building an effective team-based care model that generates new revenue and improves clinician satisfaction by reducing burnout.